{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:39:20Z","timestamp":1793032760070,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004792","name":"Minist\u00e8re de l'Enseignement Sup\u00e9rieur et de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005905","name":"Agence Fran\u00e7aise de Lutte contre le Dopage","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005905","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001962","name":"World Anti-Doping Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001962","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry & Cell Biology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.biocel.2013.07.019","type":"journal-article","created":{"date-parts":[[2013,8,2]],"date-time":"2013-08-02T12:45:49Z","timestamp":1375447549000},"page":"2444-2455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle"],"prefix":"10.1016","volume":"45","author":[{"given":"Olivier Roger","family":"Joassard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel","family":"Amirouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann Simon","family":"Gallot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine Maud","family":"Desgeorges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josiane","family":"Castells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-C\u00e9cile","family":"Durieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phan\u00e9lie","family":"Berthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien Gilles","family":"Freyssenet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biocel.2013.07.019_bib0005","doi-asserted-by":"crossref","DOI":"10.1002\/cbf.2848","article-title":"IGF and myostatin pathways are respectively induced during the earlier and the later stages of skeletal muscle hypertrophy induced by clenbuterol, a beta(2)-adrenergic agonist","author":"Abo","year":"2012","journal-title":"Cell Biochemistry and Function"},{"key":"10.1016\/j.biocel.2013.07.019_bib0010","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0300-9629(92)90026-M","article-title":"Effect of clenbuterol on skeletal muscle atrophy in mice induced by the glucocorticoid dexamethasone","volume":"102","author":"Agbenyega","year":"1992","journal-title":"Comparative Biochemistry and Physiology Part A: Physiology"},{"key":"10.1016\/j.biocel.2013.07.019_bib0015","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrm3072","article-title":"CREB and the CRTC co-activators: sensors for hormonal and metabolic signals","volume":"12","author":"Altarejos","year":"2011","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"10.1016\/j.biocel.2013.07.019_bib0020","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1210\/en.2008-0959","article-title":"Down-regulation of Akt\/mammalian target of rapamycin signaling pathway in response to myostatin overexpression in skeletal muscle","volume":"150","author":"Amirouche","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.biocel.2013.07.019_bib0025","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.mce.2009.09.028","article-title":"Involvement of cAMP\/Epac\/PI3K-dependent pathway in the antiproteolytic effect of epinephrine on rat skeletal muscle","volume":"315","author":"Baviera","year":"2010","journal-title":"Molecular Cell Endocrinology"},{"key":"10.1016\/j.biocel.2013.07.019_bib0030","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1152\/japplphysiol.01081.2003","article-title":"Beta2-adrenoceptor agonist fenoterol enhances functional repair of regenerating rat skeletal muscle after injury","volume":"96","author":"Beitzel","year":"2004","journal-title":"Journal of Applied Physiology"},{"key":"10.1016\/j.biocel.2013.07.019_bib0035","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nm1573","article-title":"SIK1 is a class II HDAC kinase that promotes survival of skeletal myocytes","volume":"13","author":"Berdeaux","year":"2007","journal-title":"Nature Medicine"},{"key":"10.1016\/j.biocel.2013.07.019_bib0040","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00424-007-0230-6","article-title":"Regulation of ubiquitin-proteasome system, caspase enzyme activities, and extracellular proteinases in rat soleus muscle in response to unloading","volume":"454","author":"Berthon","year":"2007","journal-title":"Pflugers Archiv"},{"key":"10.1016\/j.biocel.2013.07.019_bib0045","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1126\/science.1065874","article-title":"Identification of ubiquitin ligases required for skeletal muscle atrophy","volume":"294","author":"Bodine","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.biocel.2013.07.019_bib0050","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ncb1101-1014","article-title":"Akt\/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo","volume":"3","author":"Bodine","year":"2001","journal-title":"Nature Cell Biology"},{"key":"10.1016\/j.biocel.2013.07.019_bib0055","doi-asserted-by":"crossref","first-page":"19460","DOI":"10.1074\/jbc.M110.113092","article-title":"Peroxisome proliferator-activated receptor gamma coactivator 1alpha or 1beta overexpression inhibits muscle protein degradation, induction of ubiquitin ligases, and disuse atrophy","volume":"285","author":"Brault","year":"2010","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.biocel.2013.07.019_bib0060","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.cellsig.2005.03.011","article-title":"Adrenaline potentiates insulin-stimulated PKB activation via cAMP and Epac: implications for cross talk between insulin and adrenaline","volume":"17","author":"Brennesvik","year":"2005","journal-title":"Cellular Signalling"},{"key":"10.1016\/j.biocel.2013.07.019_bib0065","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.0001-6772.2003.01246.x","article-title":"Clenbuterol treatment affects myosin heavy chain isoforms and MyoD content similarly in intact and regenerated soleus muscles","volume":"180","author":"Bricout","year":"2004","journal-title":"Acta Physiologica Scandinavica"},{"key":"10.1016\/j.biocel.2013.07.019_bib0070","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.1158\/0008-5472.CAN-04-0425","article-title":"Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting","volume":"64","author":"Busquets","year":"2004","journal-title":"Cancer Research"},{"key":"10.1016\/j.biocel.2013.07.019_bib0075","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1006\/pupt.1997.0087","article-title":"The use of bronchodilators in stable chronic obstructive pulmonary disease","volume":"10","author":"Cazzola","year":"1997","journal-title":"Pulmonary Pharmacology and Therapeutics"},{"key":"10.1016\/j.biocel.2013.07.019_bib0080","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature03126","article-title":"Protein kinase A signalling via CREB controls myogenesis induced by Wnt proteins","volume":"433","author":"Chen","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.biocel.2013.07.019_bib0085","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cmet.2007.09.009","article-title":"The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle","volume":"6","author":"Clarke","year":"2007","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.biocel.2013.07.019_bib0090","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1083\/jcb.200901052","article-title":"During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation","volume":"185","author":"Cohen","year":"2009","journal-title":"Journal of Cell Biology"},{"key":"10.1016\/j.biocel.2013.07.019_bib0095","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/36362","article-title":"Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A","volume":"390","author":"Daaka","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.biocel.2013.07.019_bib0100","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/24884","article-title":"Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP","volume":"396","author":"de Rooij","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.biocel.2013.07.019_bib0105","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1210\/en.2006-1500","article-title":"Ectopic expression of myostatin induces atrophy of adult skeletal muscle by decreasing muscle gene expression","volume":"148","author":"Durieux","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.biocel.2013.07.019_bib0110","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF01120827","article-title":"Chronic effects of beta 2-adrenergic agonists on body composition and protein synthesis in the rat","volume":"4","author":"Emery","year":"1984","journal-title":"Bioscience Reports"},{"key":"10.1016\/j.biocel.2013.07.019_bib0115","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/ncb874","article-title":"A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK","volume":"4","author":"Enserink","year":"2002","journal-title":"Nature Cell Biology"},{"key":"10.1016\/j.biocel.2013.07.019_bib0120","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1172\/JCI32827","article-title":"Myosin accumulation and striated muscle myopathy result from the loss of muscle RING finger 1 and 3","volume":"117","author":"Fielitz","year":"2007","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.biocel.2013.07.019_bib0125","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2353\/ajpath.2010.090760","article-title":"Making fast-twitch dystrophic muscles bigger protects them from contraction injury and attenuates the dystrophic pathology","volume":"176","author":"Gehrig","year":"2010","journal-title":"American Journal of Pathology"},{"key":"10.1016\/j.biocel.2013.07.019_bib0130","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/j.ajpath.2011.01.005","article-title":"PGC-1alpha promotes nitric oxide antioxidant defenses and inhibits FOXO signaling against cardiac cachexia in mice","volume":"178","author":"Geng","year":"2011","journal-title":"American Journal of Pathology"},{"key":"10.1016\/j.biocel.2013.07.019_bib0135","doi-asserted-by":"crossref","first-page":"E157","DOI":"10.1152\/ajpendo.00193.2009","article-title":"Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin","volume":"297","author":"Gilson","year":"2009","journal-title":"American Journal of Physiology Endocrinology and Metabolism"},{"key":"10.1016\/j.biocel.2013.07.019_bib0140","doi-asserted-by":"crossref","first-page":"7111","DOI":"10.1073\/pnas.1232352100","article-title":"An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle","volume":"100","author":"Handschin","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.biocel.2013.07.019_bib0145","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1083\/jcb.200403069","article-title":"The TSC1-2 tumor suppressor controls insulin-PI3 K signaling via regulation of IRS proteins","volume":"166","author":"Harrington","year":"2004","journal-title":"Journal of Cell Biology"},{"key":"10.1016\/j.biocel.2013.07.019_bib0150","doi-asserted-by":"crossref","first-page":"12657","DOI":"10.1016\/S0021-9258(18)63907-9","article-title":"Phosphorylation sites on two domains of the beta 2-adrenergic receptor are involved in distinct pathways of receptor desensitization","volume":"264","author":"Hausdorff","year":"1989","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.biocel.2013.07.019_bib0155","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1534-5807(04)00107-8","article-title":"Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin","volume":"6","author":"Iezzi","year":"2004","journal-title":"Developmental Cell"},{"key":"10.1016\/j.biocel.2013.07.019_bib0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2013.06.025","article-title":"\u03b22-adrenergic agonists and the treatment of skeletal muscle wasting disorders","author":"Joassard","year":"2013","journal-title":"International Journal of Biochemistry and Cell Biology"},{"key":"10.1016\/j.biocel.2013.07.019_bib0165","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1126\/science.282.5397.2275","article-title":"A family of cAMP-binding proteins that directly activate Rap1","volume":"282","author":"Kawasaki","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.biocel.2013.07.019_bib0170","doi-asserted-by":"crossref","first-page":"18135","DOI":"10.1073\/pnas.0404341102","article-title":"Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I","volume":"101","author":"Kedar","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.biocel.2013.07.019_bib0175","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1152\/japplphysiol.00873.2006","article-title":"Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol","volume":"102","author":"Kline","year":"2007","journal-title":"Journal of Applied Physiology"},{"key":"10.1016\/j.biocel.2013.07.019_bib0180","doi-asserted-by":"crossref","first-page":"4811","DOI":"10.1113\/jphysiol.2010.196725","article-title":"Cellular mechanisms underlying temporal changes in skeletal muscle protein synthesis and breakdown during chronic {beta}-adrenoceptor stimulation in mice","volume":"588","author":"Koopman","year":"2010","journal-title":"Journal of Physiology"},{"key":"10.1016\/j.biocel.2013.07.019_bib0185","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/emboj.2008.52","article-title":"The initiation factor eIF3-f is a major target for atrogin1\/MAFbx function in skeletal muscle atrophy","volume":"27","author":"Lagirand-Cantaloube","year":"2008","journal-title":"Embo Journal"},{"key":"10.1016\/j.biocel.2013.07.019_bib0190","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1210\/me.2011-1124","article-title":"Myostatin induces degradation of sarcomeric proteins through a Smad3 signaling mechanism during skeletal muscle wasting","volume":"25","author":"Lokireddy","year":"2011","journal-title":"Molecular Endocrinology"},{"key":"10.1016\/j.biocel.2013.07.019_bib0195","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1042\/bj2640573","article-title":"Effects of clenbuterol and propranolol on muscle mass, evidence that clenbuterol stimulates muscle beta-adrenoceptors to induce hypertrophy","volume":"264","author":"MacLennan","year":"1989","journal-title":"Biochemical Journal"},{"key":"10.1016\/j.biocel.2013.07.019_bib0200","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.cmet.2007.11.001","article-title":"FoxO3 controls autophagy in skeletal muscle in vivo","volume":"6","author":"Mammucari","year":"2007","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.biocel.2013.07.019_bib0205","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/387083a0","article-title":"Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member","volume":"387","author":"McPherron","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.biocel.2013.07.019_bib0210","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cell.2007.05.021","article-title":"a ubiquitin-like protein required for autophagosome formation, mediates membrane tethering and hemifusion","volume":"130","author":"Nakatogawa","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.biocel.2013.07.019_bib0215","doi-asserted-by":"crossref","first-page":"E642","DOI":"10.1152\/ajpendo.00371.2003","article-title":"Effect of sympathetic denervation on the rate of protein synthesis in rat skeletal muscle","volume":"286","author":"Navegantes","year":"2004","journal-title":"American Journal of Physiology Endocrinology and Metabolism"},{"key":"10.1016\/j.biocel.2013.07.019_bib0220","doi-asserted-by":"crossref","first-page":"E663","DOI":"10.1152\/ajpendo.2000.279.3.E663","article-title":"Role of adrenoceptors and cAMP on the catecholamine-induced inhibition of proteolysis in rat skeletal muscle","volume":"279","author":"Navegantes","year":"2000","journal-title":"American Journal of Physiology Endocrinology and Metabolism"},{"key":"10.1016\/j.biocel.2013.07.019_bib0225","doi-asserted-by":"crossref","first-page":"E449","DOI":"10.1152\/ajpendo.2001.281.3.E449","article-title":"Catecholamines inhibit Ca(2+)-dependent proteolysis in rat skeletal muscle through beta(2)-adrenoceptors and cAMP","volume":"281","author":"Navegantes","year":"2001","journal-title":"American Journal of Physiology Endocrinology and Metabolism"},{"key":"10.1016\/j.biocel.2013.07.019_bib0230","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1210\/en.2007-1202","article-title":"The orphan nuclear receptor, NOR-1, a target of beta-adrenergic signaling, regulates gene expression that controls oxidative metabolism in skeletal muscle","volume":"149","author":"Pearen","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.biocel.2013.07.019_bib0235","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/j.biocel.2013.07.019_bib0240","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1096\/fj.11-180968","article-title":"Muscle actin is polyubiquitinylated in vitro and in vivo and targeted for breakdown by the E3 ligase MuRF1","volume":"25","author":"Polge","year":"2011","journal-title":"Faseb Journal"},{"key":"10.1016\/j.biocel.2013.07.019_bib0245","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/ncb1101-1009","article-title":"Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K\/Akt\/mTOR and PI(3)K\/Akt\/GSK3 pathways","volume":"3","author":"Rommel","year":"2001","journal-title":"Nature Cell Biology"},{"key":"10.1016\/j.biocel.2013.07.019_bib0250","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1476-5381.1987.tb11211.x","article-title":"Changes in tissue blood flow and beta-receptor density of skeletal muscle in rats treated with the beta2-adrenoceptor agonist clenbuterol","volume":"90","author":"Rothwell","year":"1987","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.biocel.2013.07.019_bib0255","doi-asserted-by":"crossref","first-page":"R1386","DOI":"10.1152\/ajpregu.00324.2002","article-title":"Lynch GS. Beta 2-agonist fenoterol has greater effects on contractile function of rat skeletal muscles than clenbuterol","volume":"283","author":"Ryall","year":"2002","journal-title":"American Journal of Physiology Regulatory Integrative and Comparative Physiology"},{"key":"10.1016\/j.biocel.2013.07.019_bib0260","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1113\/jphysiol.2003.056770","article-title":"Lynch GS. Beta 2-agonist administration reverses muscle wasting and improves muscle function in aged rats","volume":"555","author":"Ryall","year":"2004","journal-title":"Journal of Physiology"},{"key":"10.1016\/j.biocel.2013.07.019_bib0265","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/sj.bjp.0706669","article-title":"Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses","volume":"147","author":"Ryall","year":"2006","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.biocel.2013.07.019_bib0270","doi-asserted-by":"crossref","first-page":"16260","DOI":"10.1073\/pnas.0607795103","article-title":"PGC-1{alpha} protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription","volume":"103","author":"Sandri","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.biocel.2013.07.019_bib0275","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0092-8674(04)00400-3","article-title":"Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy","volume":"117","author":"Sandri","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.biocel.2013.07.019_bib0280","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1124\/mol.58.5.1162","article-title":"Localization of the sites mediating desensitization of the beta(2)-adrenergic receptor by the GRK pathway","volume":"58","author":"Seibold","year":"2000","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.biocel.2013.07.019_bib0285","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1074\/jbc.M506576200","article-title":"beta-arrestin-dependent, G protein-independent ERK1\/2 activation by the beta2 adrenergic receptor","volume":"281","author":"Shenoy","year":"2006","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.biocel.2013.07.019_bib0290","doi-asserted-by":"crossref","first-page":"C1681","DOI":"10.1152\/ajpcell.00466.2006","article-title":"Extracellular signal-regulated kinase pathway is differentially involved in beta-agonist-induced hypertrophy in slow and fast muscles","volume":"292","author":"Shi","year":"2007","journal-title":"American Journal of Physiology Cell Physiology"},{"key":"10.1016\/j.biocel.2013.07.019_bib0295","doi-asserted-by":"crossref","first-page":"E676","DOI":"10.1152\/ajpendo.2001.281.4.E676","article-title":"Elevated IGF-II mRNA and phosphorylation of 4E-BP1 and p70(S6k) in muscle showing clenbuterol-induced anabolism","volume":"281","author":"Sneddon","year":"2001","journal-title":"American Journal of Physiology Endocrinology and Metabolism"},{"key":"10.1016\/j.biocel.2013.07.019_bib0300","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1097-2765(04)00211-4","article-title":"The IGF-1\/PI3K\/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors","volume":"14","author":"Stitt","year":"2004","journal-title":"Molecular Cell"},{"key":"10.1016\/j.biocel.2013.07.019_bib0305","doi-asserted-by":"crossref","first-page":"C1674","DOI":"10.1152\/ajpcell.1998.274.6.C1674","article-title":"Expression of adenylyl cyclase mRNAs in the denervated and in the developing mouse skeletal muscle","volume":"274","author":"Suzuki","year":"1998","journal-title":"American Journal of Physiology"},{"key":"10.1016\/j.biocel.2013.07.019_bib0310","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1074\/jbc.M411346200","article-title":"Degradation of MyoD mediated by the SCF (MAFbx) ubiquitin ligase","volume":"280","author":"Tintignac","year":"2005","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.biocel.2013.07.019_bib0315","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1128\/MCB.26.1.63-76.2006","article-title":"Nutrients suppress phosphatidylinositol 3-kinase\/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation","volume":"26","author":"Tzatsos","year":"2006","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.biocel.2013.07.019_bib0320","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1183\/09031936.96.09081684","article-title":"Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action","volume":"9","author":"van Noord","year":"1996","journal-title":"European Respiratory Journal"},{"key":"10.1016\/j.biocel.2013.07.019_bib0325","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1038\/emboj.2010.74","article-title":"GATE-16\/GABARAP subfamilies are both essential yet act differently in autophagosome biogenesis","volume":"29","author":"Weidberg","year":"2010","journal-title":"Embo Journal"},{"key":"10.1016\/j.biocel.2013.07.019_bib0330","doi-asserted-by":"crossref","first-page":"20405","DOI":"10.1073\/pnas.0911570106","article-title":"Increased muscle PGC-1alpha expression protects from sarcopenia and metabolic disease during aging","volume":"106","author":"Wenz","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.biocel.2013.07.019_bib0335","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1091\/mbc.e07-12-1292","article-title":"Atg8 controls phagophore expansion during autophagosome formation","volume":"19","author":"Xie","year":"2008","journal-title":"Molecular Biology of the Cell"},{"key":"10.1016\/j.biocel.2013.07.019_bib0340","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1152\/japplphysiol.00448.2004","article-title":"Clenbuterol induces muscle-specific attenuation of atrophy through effects on the ubiquitin-proteasome pathway","volume":"99","author":"Yimlamai","year":"2005","journal-title":"Journal of Applied Physiology"},{"key":"10.1016\/j.biocel.2013.07.019_bib0345","first-page":"E152","article-title":"Clenbuterol, a beta 2-agonist, retards atrophy in denervated muscles","volume":"252","author":"Zeman","year":"1987","journal-title":"American Journal of Physiology"},{"key":"10.1016\/j.biocel.2013.07.019_bib0350","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.cmet.2007.11.004","article-title":"FoxO3 coordinately activates protein degradation by the autophagic\/lysosomal and proteasomal pathways in atrophying muscle cells","volume":"6","author":"Zhao","year":"2007","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.biocel.2013.07.019_bib0355","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1073\/pnas.98.4.1607","article-title":"Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes","volume":"98","author":"Zhu","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"}],"container-title":["The International Journal of Biochemistry & Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272513002422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272513002422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:03:13Z","timestamp":1793030593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272513002422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":71,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S1357272513002422"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2013.07.019","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2013.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}